Ronald Hoekstra

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

Ferry A.L.M. Eskens, Herlinde Dumez, Ronald Hoekstra et al. · European Journal of Cancer · 2003 · 223 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Survival and Long-Term Neurodevelopmental Outcome of Extremely Premature Infants Born at 23–26 Weeks’ Gestational Age at a Tertiary Center

Ronald Hoekstra, Teresa Ferrara, Robert J. Couser et al. · PEDIATRICS · 2004 · 196 citations

Public Health, Child Health, Pediatrics +17

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld et al. · The Lancet Oncology · 2023 · 168 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.

Ronald Hoekstra, J. Craig Jackson, Thomas F. Myers et al. · PubMed · 1991 · 136 citations

Public Health, Pediatrics, Pharmacotherapy +17

Improved Neonatal Survival Following Multiple Doses of Bovine Surfactant in Very Premature Neonates at Risk for Respiratory Distress Syndrome

Ronald Hoekstra, J. Craig Jackson, Thomas F. Myers et al. · PEDIATRICS · 1991 · 127 citations

Public Health, Pediatrics, Neonatal Health +16